PMID- 7890708 OWN - NLM STAT- MEDLINE DCOM- 19950418 LR - 20210210 IS - 0021-9258 (Print) IS - 0021-9258 (Linking) VI - 270 IP - 11 DP - 1995 Mar 17 TI - Signal transduction and ligand specificity of the human monocyte chemoattractant protein-1 receptor in transfected embryonic kidney cells. PG - 5786-92 AB - We have examined the ligand specificity and signal transduction pathways of a recently cloned receptor for monocyte chemoattractant protein-1 (MCP-1). In human 293 cells stably transfected with the MCP-1 receptor, MCP-1 bound specifically with high affinity (Kd = 260 pM) and induced a rapid mobilization of calcium from intracellular stores. The closely related chemokines MIP-1 alpha, MIP-1 beta, RANTES, interleukin 8 (IL-8), and Gro-alpha were inactive at concentrations as high as 300 nM. Activation of the MCP-1 receptor potently inhibited adenylyl cyclase with an IC50 = 90 pM. Activation of the MIP-1 alpha/RANTES receptor also mediated inhibition of adenylyl cyclase activity but with a different pharmacological profile: MIP-1 alpha (110 pM, IC50), RANTES (140 pM), MIP-1 beta (10 nM), and MCP-1 (820 nM). Mobilization of intracellular calcium and inhibition of adenylyl cyclase were blocked by pertussis toxin, suggesting that the MCP-1 receptor coupled to G alpha i. These results demonstrate that the MCP-1 receptor binds and signals in response to picomolar concentrations of MCP-1 in a highly specific manner. Signaling was manifested as mobilization of intracellular calcium and inhibition of adenylyl cyclase and was mediated by a pertussis toxin-sensitive G-protein(s). FAU - Myers, S J AU - Myers SJ AD - Gladstone Institute of Cardiovascular Disease, San Francisco, California 94141-9100. FAU - Wong, L M AU - Wong LM FAU - Charo, I F AU - Charo IF LA - eng GR - HL52773/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - 0 (Adenylyl Cyclase Inhibitors) RN - 0 (CCR2 protein, human) RN - 0 (Chemokine CCL2) RN - 0 (Chemotactic Factors) RN - 0 (Cytokines) RN - 0 (Iodine Radioisotopes) RN - 0 (Ligands) RN - 0 (Lymphokines) RN - 0 (Receptors, CCR2) RN - 0 (Receptors, Chemokine) RN - 0 (Receptors, Cytokine) RN - 0 (Recombinant Proteins) RN - EC 3.1.4.- (Type C Phospholipases) RN - SY7Q814VUP (Calcium) SB - IM MH - Adenylyl Cyclase Inhibitors MH - Binding, Competitive MH - Calcium/metabolism MH - Cell Line MH - Chemokine CCL2 MH - Chemotactic Factors/*metabolism MH - Cytokines/*pharmacology MH - Embryo, Mammalian MH - Humans MH - Iodine Radioisotopes MH - Kidney MH - Kinetics MH - Ligands MH - Lymphokines/pharmacology MH - Receptors, CCR2 MH - *Receptors, Chemokine MH - Receptors, Cytokine/*metabolism MH - Recombinant Proteins/metabolism MH - *Signal Transduction MH - Substrate Specificity MH - Transfection MH - Type C Phospholipases/metabolism EDAT- 1995/03/17 00:00 MHDA- 1995/03/17 00:01 CRDT- 1995/03/17 00:00 PHST- 1995/03/17 00:00 [pubmed] PHST- 1995/03/17 00:01 [medline] PHST- 1995/03/17 00:00 [entrez] AID - S0021-9258(18)81426-0 [pii] AID - 10.1074/jbc.270.11.5786 [doi] PST - ppublish SO - J Biol Chem. 1995 Mar 17;270(11):5786-92. doi: 10.1074/jbc.270.11.5786.